You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has announced the appointments of Patrik Renblad as Vice President Finance and Lise Agersted as Director of Operational R&D. “We are happy to welcome both Patrik and Lise to the SynAct team,” says SynAct’s CEO Jeppe Øvlesen. “Both are important additions as SynAct pushes Already a subscriber Login…
The company has announced the appointment of two new board members, Erik Walldén and Stefan Löfås. Both members will play a key role in bolstering the full execution of the company’s corporate strategy to grow business in the research market and develop much needed solutions for clinical diaAlready a subscriber…
Scandinavian Biopharma is strengthening its organization by recruiting Anna Hill to the new position as Clinical Operations Manager. Anna Hill will have the overall responsibility for the company's clinical development program and be responsible for ensuring that ongoing and future clinical trialAlready a subscriber Login You have read all your…
Nordic Nanovector appoints Dominic Smethurst as Interim Chief Medical Officer with immediate effect. Smethurst replaces Lisa Rojkjaer, who after a handover period will leave Nordic Nanovector to pursue other career opportunities. “I am pleased that we have been able to appoint Dominic as ourAlready a subscriber Login You have read…
